Bruker Corporation (BRKR) executive sells 2,000 shares after option exercise

Rhea-AI Filing Summary

Bruker Corporation executive Mark Munch reported an options exercise and share sale. On 01/15/2026 he exercised stock options for 2,000 shares of common stock at $22.19 per share, then sold 2,000 shares of common stock at $49.20 per share on the same date. The filing states that the sales were made under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person. After these transactions, he beneficially owned 128,443 shares of Bruker common stock directly, along with 16,000 stock options that remain outstanding.

Insider Trade Summary

Exercise and Sale: 2,000 shares ($54K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Munch Mark

Role EXEC VP&PRES BRUKER NANO INC.

Sold 2,000 shs ($98K)

Approx. gross sale proceeds $98K

Approx. exercise cost $44K

Approx. pre-tax spread $54K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Purchase)	2,000	$0.00	$0.00
Exercise	Common Stock	2,000	$22.19	$44K
Sale	Common Stock	2,000	$49.20	$98K

Holdings After Transaction: Stock Option (Right to Purchase) — 16,000 shares (Direct); Common Stock — 128,443 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
2. F2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.

FAQ

What insider transaction did BRKR executive Mark Munch report?

Mark Munch, an executive vice president at Bruker Corporation (BRKR), reported exercising stock options for 2,000 shares and selling 2,000 shares of common stock on 01/15/2026.

At what prices did Mark Munch exercise and sell Bruker (BRKR) shares?

He exercised stock options at $22.19 per share and sold 2,000 shares of Bruker common stock at $49.20 per share on 01/15/2026.

How many Bruker (BRKR) shares does Mark Munch own after this Form 4?

Following the reported transactions, Mark Munch beneficially owned 128,443 shares of Bruker common stock directly.

How many Bruker stock options does Mark Munch still hold?

After the 2,000-option exercise, he held 16,000 stock options (right to purchase Bruker common stock) beneficially owned directly.

Were the Bruker (BRKR) share sales by Mark Munch under a Rule 10b5-1 plan?

Yes. The filing explains that the sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

When were the stock options reported in this Bruker Form 4 originally granted?

The stock option was granted on October 4, 2016 and vests in four installments on the first through fourth anniversaries of that original grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/16/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Munch Mark

(Last) (First) (Middle)

BRUKER CORPORATION

40 MANNING ROAD

(Street)

BILLERICA MA 01821

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EXEC VP&PRES BRUKER NANO INC.

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		M		2,000	A	$22.19	130,443	D
Common Stock	01/15/2026		S		2,000(1)	D	$49.2	128,443	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$22.19	01/15/2026		M			2,000	(2)	10/04/2026	Common Stock	2,000	$0	16,000	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.

	/s/ Michael Simone, Attorney-in-Fact	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.